New products and innovation helped drive sales of depilatories. According to SymphonyIRI Group, sales of depilatories rose more than 15% to $23.4 million for the most recent 12 weeks ended Nov. 27 at food, drug and mass (excluding Walmart).
According to the American Diabetes Association’s latest figures, 79 million Americans have prediabetes, but only 1-out-of-10 knows it. That suggests a terrific upside in the market of diabetes-testing supplies and diabetes-supportive products as more of those Americans become aware of their condition.
Record-breaking attendance and four panel discussions on such topics as specialty pharmacy and diabetes set the stage for the 13th annual Drug Store News Industry Issues Summit held on Nov. 29 in New York City.
With the patent cliff and subsequent innovation drought moving closer, generic drug makers are looking to move up the value chain and pursue new sources of revenue, and of all the piles of pay dirt out there, biosimilars represent one of the closest things to an El Dorado, though regulations won’t take their final form for a while.